Brain Delivery of Thyrotropin-Releasing Hormone via a Novel Prodrug Approach
Using thyrotropin-releasing hormone (TRH) as a model, we explored whether synergistic combination of lipoamino acid(s) and a linker cleaved by prolyl oligopeptidase (POP) can be used as a promoiety for prodrug design for the preferential brain delivery of the peptide. A representative prodrug based...
Main Authors: | Katalin Prokai-Tatrai, Daniel L. De La Cruz, Vien Nguyen, Benjamin P. Ross, Istvan Toth, Laszlo Prokai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/7/349 |
Similar Items
-
[β-Glu<sup>2</sup>]TRH Is a Functional Antagonist of Thyrotropin-Releasing Hormone (TRH) in the Rodent Brain
by: Katalin Prokai-Tatrai, et al.
Published: (2021-06-01) -
The Antagonist pGlu-βGlu-Pro-NH<sub>2</sub> Binds to an Allosteric Site of the Thyrotropin-Releasing Hormone Receptor
by: Daniel L. De La Cruz, et al.
Published: (2021-09-01) -
Design and Exploratory Neuropharmacological Evaluation of Novel Thyrotropin-Releasing Hormone Analogs and Their Brain-Targeting Bioprecursor Prodrugs
by: Laszlo Prokai, et al.
Published: (2013-05-01) -
CNS-Selective Estrogen Therapy
by: Katalin Prokai-Tatrai, et al.
Published: (2019-08-01) -
Proteomics-Based Retinal Target Engagement Analysis and Retina-Targeted Delivery of 17β-Estradiol by the DHED Prodrug for Ocular Neurotherapy in Males
by: Katalin Prokai-Tatrai, et al.
Published: (2021-09-01)